학술논문
Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
Document Type
Article
Author
Usmani, S.Z.; Nahi, H.; Legiec, W.; Grosicki, S.; Vorobyev, V.; Spicka, I.; Hungria, V.; Korenkova, S.; Bahlis, N.J.; Flogegard, M.; Bladé, J.; Moreau, P.; Kaiser, M.; Iida, S.; Laubach, J.; Magen, H.; Cavo, M.; Hulin, C.; White, D.; De Stefano, V.; Lantz, K.; O'Rourke, L.; Heuck, C.; Delioukina, M.; Nnane, I.; Qi, M.; Qin, X.; Mateos, M.-V.
Source
In: Haematologica . (Haematologica, October 2022, 107(10):2408-2417)
Subject
Language
English
ISSN
15928721
03906078
03906078